Renzhi Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Renzhi Gao has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Bizeng Zhao
Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600# Yishan Road, Shanghai 200233, China
2 shared publications Yang Wang
Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China
2 shared publications- Zongping Xie
Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China
2 shared publications Ji Yuan
Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai, 200233, China
1 shared publicationJieyuan Zhang
Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China
1 shared publicationJuntao Zhang
Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai, 200233, China
1 shared publication
Latest Publications
- Open Access
- 16 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2603001
Gait differences after ACL reconstruction versus healthy controls: a three-level meta-analysis of kinematics, kinetics, and spatiotemporal parameters
This meta-analysis was designed to evaluate whether individuals following ACL reconstruction exhibit normalized gait biomechanics when compared to healthy controls. This review was conducted across five databases: PubMed, Embase, The Cochrane Library, Web of Science and EBSCOhost-SportDiscus, yielding a total of 5,251 records, with 21 qualified studies (52 independent samples from 861 participants; based on available data, the mean age was 26.5 ± 4.3 years and 51.3% were female) eligible for quantitative synthesis following rigorous screening. A three-level meta-analysis model was implemented to address effect size dependencies. Six gait parameters were analyzed, including kinematic variables (peak knee flexion and extension angles during stance), kinetic variables (peak external knee flexion and extension moments during stance) and spatiotemporal variables (stride length and walking speed). Among the six gait parameters that were analyzed, only the peak knee extension angle during stance (k = 9, d = 0.83, 95% CI: 0.26-1.40, I2 = 77.53%, p = 0.01) showed a significant difference between ACL reconstruction patients and healthy controls. However, peak knee flexion angle, peak external knee flexion and extension moments during stance, stride length and walking speed were not significantly different between groups (p > 0.05). Meta-regression identified a significant time-dependent improvement only for knee extension angle (F = 5.656, p = 0.049), while postoperative duration had no significant effect on other outcomes. This meta-analysis shows that the majority of gait parameters during stance, including peak knee flexion angle, external knee flexion and extension moments, stride length and walking speed, do not differ significantly between individuals with ACL reconstruction and healthy controls. Only peak knee extension angle remained impaired, though it showed signs of improvement over time. Persistent knee extension deficits emphasize the need for targeted quadriceps and knee control training as a key focus for long-term ACLR rehabilitation.
- 16 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2603001
Open AccessGait differences after ACL reconstruction versus healthy controls: a three-level meta-analysis of kinematics, kinetics, and spatiotemporal parameters
This meta-analysis was designed to evaluate whether individuals following ACL reconstruction exhibit normalized gait biomechanics when compared to healthy controls. This review was conducted across five databases: PubMed, Embase, The Cochrane Library, Web of Science and EBSCOhost-SportDiscus, yielding a total of 5,251 records, with 21 qualified studies (52 independent samples from 861 participants; based on available data, the mean age was 26.5 ± 4.3 years and 51.3% were female) eligible for quantitative synthesis following rigorous screening. A three-level meta-analysis model was implemented to address effect size dependencies. Six gait parameters were analyzed, including kinematic variables (peak knee flexion and extension angles during stance), kinetic variables (peak external knee flexion and extension moments during stance) and spatiotemporal variables (stride length and walking speed). Among the six gait parameters that were analyzed, only the peak knee extension angle during stance (k = 9, d = 0.83, 95% CI: 0.26-1.40, I2 = 77.53%, p = 0.01) showed a significant difference between ACL reconstruction patients and healthy controls. However, peak knee flexion angle, peak external knee flexion and extension moments during stance, stride length and walking speed were not significantly different between groups (p > 0.05). Meta-regression identified a significant time-dependent improvement only for knee extension angle (F = 5.656, p = 0.049), while postoperative duration had no significant effect on other outcomes. This meta-analysis shows that the majority of gait parameters during stance, including peak knee flexion angle, external knee flexion and extension moments, stride length and walking speed, do not differ significantly between individuals with ACL reconstruction and healthy controls. Only peak knee extension angle remained impaired, though it showed signs of improvement over time. Persistent knee extension deficits emphasize the need for targeted quadriceps and knee control training as a key focus for long-term ACLR rehabilitation.
- Open Access
- 26 August 2022
- Published by KEAI Publishing in Bioactive Materials
- Vol. 21, 194-208
Large extracellular vesicles secreted by human iPSC-derived MSCs ameliorate tendinopathy via regulating macrophage heterogeneity
Tendinopathy is a common musculoskeletal disorder which results in chronic pain and reduced performance. The therapeutic effect of stem cell derived-small extracellular vesicles (sEVs) for tendinopathy has been validated in recent years. However, whether large extracellular vesicles (lEVs), another subset of extracellular vesicles, possesses the ability for the improvement of tendinopathy remains unknown. Here, we showed that lEVs secreted from iPSC-derived MSCs (iMSC-lEVs) significantly mitigated pain derived from tendinopathy in rats. Immunohistochemical analysis showed that iMSC-lEVs regulated the heterogeneity of infiltrated macrophages and several inflammatory cytokines in rat tendon tissue. Meanwhile, in vitro experiments revealed that the M1 pro-inflammatory macrophages were repolarized towards M2 anti-inflammatory macrophages by iMSC-lEVs, and this effect was mediated by regulating p38 MAPK pathway. Moreover, liquid chromatography-tandem mass spectrometry analysis identified 2208 proteins encapsulated in iMSC-lEVs, including 134 new-found proteins beyond current Vesiclepedia database. By bioinformatics and Western blot analyses, we showed that DUSP2 and DUSP3, the negative regulator of p38 phosphorylation, were enriched in iMSC-lEVs and could be transported to macrophages. Further, the immunomodulatory effect of iMSC-lEVs on macrophages was validated in explant tendon tissue from tendinopathy patients. Taken together, our results demonstrate that iMSC-lEVs could reduce inflammation in tendinopathy by regulating macrophage heterogeneity, which is mediated via the p38 MAPK pathway by delivery of DUSP2 and DUSP3, and might be a promising candidate for tendinopathy therapy.
- 26 August 2022
- Published by KEAI Publishing in Bioactive Materials
- Vol. 21, 194-208
Open AccessLarge extracellular vesicles secreted by human iPSC-derived MSCs ameliorate tendinopathy via regulating macrophage heterogeneity
Tendinopathy is a common musculoskeletal disorder which results in chronic pain and reduced performance. The therapeutic effect of stem cell derived-small extracellular vesicles (sEVs) for tendinopathy has been validated in recent years. However, whether large extracellular vesicles (lEVs), another subset of extracellular vesicles, possesses the ability for the improvement of tendinopathy remains unknown. Here, we showed that lEVs secreted from iPSC-derived MSCs (iMSC-lEVs) significantly mitigated pain derived from tendinopathy in rats. Immunohistochemical analysis showed that iMSC-lEVs regulated the heterogeneity of infiltrated macrophages and several inflammatory cytokines in rat tendon tissue. Meanwhile, in vitro experiments revealed that the M1 pro-inflammatory macrophages were repolarized towards M2 anti-inflammatory macrophages by iMSC-lEVs, and this effect was mediated by regulating p38 MAPK pathway. Moreover, liquid chromatography-tandem mass spectrometry analysis identified 2208 proteins encapsulated in iMSC-lEVs, including 134 new-found proteins beyond current Vesiclepedia database. By bioinformatics and Western blot analyses, we showed that DUSP2 and DUSP3, the negative regulator of p38 phosphorylation, were enriched in iMSC-lEVs and could be transported to macrophages. Further, the immunomodulatory effect of iMSC-lEVs on macrophages was validated in explant tendon tissue from tendinopathy patients. Taken together, our results demonstrate that iMSC-lEVs could reduce inflammation in tendinopathy by regulating macrophage heterogeneity, which is mediated via the p38 MAPK pathway by delivery of DUSP2 and DUSP3, and might be a promising candidate for tendinopathy therapy.
- Open Access
- 15 March 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (8) , 513-529
Small Extracellular Vesicles From iPSC-Derived Mesenchymal Stem Cells Ameliorate Tendinopathy Pain by Inhibiting Mast Cell Activation
Aim: This study aimed to explore the effect of small extracellular vesicles from induced pluripotent stem cell-derived mesenchymal stem cells (iMSC-sEVs) on acute pain and investigate the underlyin...
- 15 March 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (8) , 513-529
Open AccessSmall Extracellular Vesicles From iPSC-Derived Mesenchymal Stem Cells Ameliorate Tendinopathy Pain by Inhibiting Mast Cell Activation
Aim: This study aimed to explore the effect of small extracellular vesicles from induced pluripotent stem cell-derived mesenchymal stem cells (iMSC-sEVs) on acute pain and investigate the underlyin...